Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Director departure
Appointed director
|
|
Arcadia Biosciences, Inc. (RKDA)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/07/2023 |
4
| Schaefer Thomas J. (CFO) has filed a Form 4 on Arcadia Biosciences, Inc.|
Txns:
| Bought 649 shares
@ $3.67, valued at
$2.4k
|
|
| 06/16/2023 |
4
| Carosella Deborah D (Director) has filed a Form 4 on Arcadia Biosciences, Inc.|
Txns:
| Granted 937 options to buy
@ $4.8, valued at
$4.5k
|
|
| 06/16/2023 |
4
| Yoder Amy (Director) has filed a Form 4 on Arcadia Biosciences, Inc.|
Txns:
| Granted 937 options to buy
@ $4.8, valued at
$4.5k
|
|
| 06/16/2023 |
4
| Bolles Albert D. (Director) has filed a Form 4 on Arcadia Biosciences, Inc.|
Txns:
| Granted 937 options to buy
@ $4.8, valued at
$4.5k
|
|
| 06/16/2023 |
4
| WALLER GREGORY D (Director) has filed a Form 4 on Arcadia Biosciences, Inc.|
Txns:
| Granted 937 options to buy
@ $4.8, valued at
$4.5k
|
|
| 06/16/2023 |
4
| Murray Lilian Shackelford (Director) has filed a Form 4 on Arcadia Biosciences, Inc.|
Txns:
| Granted 937 options to buy
@ $4.8, valued at
$4.5k
|
|
| 06/16/2023 |
4
| Comcowich Kevin (Director) has filed a Form 4 on Arcadia Biosciences, Inc.|
Txns:
| Granted 2,186 options to buy
@ $4.8, valued at
$10.5k
|
|
| 05/30/2023 |
4
| Jacot Stanley Jr (CEO) has filed a Form 4 on Arcadia Biosciences, Inc.|
Txns:
| Bought 5,000 shares
@ $4.31, valued at
$21.6k
|
|
| 04/28/2023 |
4
| PITLIK LAURA (Chief Marketing Officer) has filed a Form 4 on Arcadia Biosciences, Inc.|
Txns:
| Granted 1,500 options to buy
@ $7.55, valued at
$11.3k
|
|
| 04/28/2023 |
4
| Jacot Stanley Jr (CEO) has filed a Form 4 on Arcadia Biosciences, Inc.|
Txns:
| Granted 1,500 options to buy
@ $7.55, valued at
$11.3k
|
|
| 04/28/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/02/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/05/2023 |
4
| Schaefer Thomas J. (CFO) has filed a Form 4 on Arcadia Biosciences, Inc.|
Txns:
| Granted 50,000 options to buy
@ $0.28, valued at
$14k
|
|
| 08/18/2022 |
4
| PITLIK LAURA (Chief Marketing Officer) has filed a Form 4 on Arcadia Biosciences, Inc.|
Txns:
| Granted 23,000 options to buy
@ $0.94, valued at
$21.6k
|
|
| 08/18/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/03/2022 |
4
| Comcowich Kevin (Director) has filed a Form 4 on Arcadia Biosciences, Inc.|
Txns:
| Granted 55,114 options to buy
@ $1.34, valued at
$73.9k
|
|
| 06/03/2022 |
4
| Bolles Albert D. (Director) has filed a Form 4 on Arcadia Biosciences, Inc.|
Txns:
| Granted 23,620 options to buy
@ $1.34, valued at
$31.7k
|
|
| 06/03/2022 |
4
| Murray Lilian Shackelford (Director) has filed a Form 4 on Arcadia Biosciences, Inc.|
Txns:
| Granted 23,620 options to buy
@ $1.34, valued at
$31.7k
|
|
| 06/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/03/2022 |
4
| Carosella Deborah D (Director) has filed a Form 4 on Arcadia Biosciences, Inc.|
Txns:
| Granted 23,620 options to buy
@ $1.34, valued at
$31.7k
|
|
| 04/13/2022 |
4
| PITLIK LAURA (Chief Marketing Officer) has filed a Form 4 on Arcadia Biosciences, Inc.|
Txns:
| Granted 31,000 options to buy
@ $1.27, valued at
$39.4k
Granted 23,000 options to buy
@ $1.27, valued at
$29.2k
|
|
| 04/13/2022 |
4
| Haley Pamela (CFO) has filed a Form 4 on Arcadia Biosciences, Inc.|
Txns:
| Granted 50,000 options to buy
@ $1.27, valued at
$63.5k
Granted 38,000 options to buy
@ $1.27, valued at
$48.3k
|
|
| 02/04/2022 |
4
| Jacot Stanley Jr (CEO) has filed a Form 4 on Arcadia Biosciences, Inc.|
Txns:
| Granted 316,108 options to buy
@ $0.91, valued at
$287.7k
|
|
| 07/13/2021 |
4
| PITLIK LAURA (Chief Marketing Officer) has filed a Form 4 on Arcadia Biosciences, Inc.|
Txns:
| Granted 75,000 options to buy
@ $2.8, valued at
$210k
|
|
| 06/04/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/04/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/04/2021 |
4
| Carosella Deborah D (Director) has filed a Form 4 on Arcadia Biosciences, Inc.|
Txns:
| Granted 10,935 options to buy
@ $2.89, valued at
$31.6k
|
|
| 06/04/2021 |
4
| Comcowich Kevin (Director) has filed a Form 4 on Arcadia Biosciences, Inc.|
Txns:
| Granted 25,514 options to buy
@ $2.89, valued at
$73.7k
|
|
| 06/04/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/04/2021 |
4
| Bolles Albert D. (Director) has filed a Form 4 on Arcadia Biosciences, Inc.|
Txns:
| Granted 10,935 options to buy
@ $2.89, valued at
$31.6k
|
|
| 05/20/2021 |
4
| Cuvelier Chris (Chief Growth Officer) has filed a Form 4 on Arcadia Biosciences, Inc.|
Txns:
| Granted 100,000 options to buy
@ $2.61, valued at
$261k
|
|
| 02/24/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|
|
|